(Q44397510)

English

Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Hitoshi Omi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Naotsuka Okayama

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Manabu Shimizu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tatsuya Fukutomi

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kenro Imaeda

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Masahiro Okouchi

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Makoto Itoh

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Microvascular Research

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

118-124

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Endothelial dysfunction in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Assessment of leukocyte involvement during ischemia and reperfusion of intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

The physiology and pathophysiology of the nitric oxide/superoxide system

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

The fluid mosaic model of the structure of cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications

1 reference

https://api.crossref.org/works/10.1016%2FS0026-2862%2802%2900033-X

7 January 2021

Identifiers

10.1016/S0026-2862(02)00033-X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44397510&oldid=2033064949"